+919405117673
Pomalidomide 1mg/2mg/4mg Capsules Treatment Guide Global Multiple Myeloma Therapy by Cordium Pharma
What is Pomalidomide?

Pomalidomide is an advanced immunomodulatory medicine (IMiD) used for treating relapsed and refractory multiple myeloma (RRMM) in adult patients who have previously received other therapies.

Pomalidomide helps slow the growth of cancer cells, strengthens the immune system, and improves patient outcomes when used in combination with other medicines such as dexamethasone.

Cordium Pharmaceuticals Pvt Ltd is a trusted Indian pharmaceutical exporter supplying high-quality Pomalidomide 1mg, 2mg, and 4mg capsules to international markets.

Available Strengths
Pomalidomide 1mg Capsules

Used for:

Dose adjustments
Maintenance therapy
Patients requiring lower doses
Managing treatment-related side effects
Pomalidomide 2mg Capsules

Used for:

Intermediate dosage regimens
Personalized treatment plans
Combination therapies
Pomalidomide 4mg Capsules

Most commonly prescribed strength for:

Relapsed multiple myeloma treatment
Standard treatment protocols
Combination with dexamethasone
What Conditions Does Pomalidomide Treat?

Pomalidomide is primarily indicated for:

✅ Relapsed Multiple Myeloma

✅ Refractory Multiple Myeloma

✅ Multiple Myeloma after prior therapies

It is prescribed when patients have previously received treatments such as:

Lenalidomide
Bortezomib
Proteasome inhibitors
Other anti-myeloma therapies
How Does Pomalidomide Work?

Pomalidomide works through multiple mechanisms:

1. Activates the Immune System

Enhances T-cell and natural killer (NK) cell activity to attack cancer cells.

2. Inhibits Cancer Cell Growth

Prevents myeloma cells from multiplying.

3. Reduces Blood Supply to Tumors

Blocks angiogenesis, reducing tumor nourishment.

4. Promotes Cancer Cell Death

Triggers apoptosis in malignant cells.

Benefits of Pomalidomide Capsules
High treatment efficacy
Improved progression-free survival
Oral administration convenience
Personalized dosing options
Widely used in global oncology protocols
Suitable for combination therapies
Recommended Dosage

Always use under oncologist supervision.

The commonly recommended dose is:

Pomalidomide 4mg once daily for 21 days followed by 7 days off in a 28-day cycle.

Dosage may be adjusted to:

1mg
2mg
3mg
4mg

Depending on:

Kidney function
Liver function
Blood counts
Treatment tolerance
Possible Side Effects

Patients may experience:

Fatigue
Anemia
Low white blood cell count
Low platelet count
Constipation
Nausea
Diarrhea
Fever
Peripheral neuropathy
Shortness of breath

Seek immediate medical attention for severe symptoms.

Important Safety Information

⚠️ Use only under specialist supervision.

⚠️ Avoid use during pregnancy due to severe birth defect risks.

⚠️ Regular blood monitoring is essential.

⚠️ Follow thromboembolism prevention recommendations.

⚠️ Do not self-medicate.

Why Choose Cordium Pharmaceuticals Pvt Ltd?

Cordium Pharmaceuticals Pvt Ltd is an emerging global pharmaceutical company committed to delivering high-quality oncology medicines worldwide.

Our Advantages

✅ WHO-GMP compliant manufacturing

✅ International quality standards

✅ Competitive pricing

✅ Reliable global exports

✅ Timely shipments

✅ Regulatory support

✅ Professional customer service

Countries We Export Pomalidomide Capsules To
Africa

🇰🇪 Kenya

🇳🇬 Nigeria

🇬🇭 Ghana

🇿🇦 South Africa

Asia

🇵🇭 Philippines

🇻🇳 Vietnam

🇺🇿 Uzbekistan

🇰🇿 Kazakhstan

Middle East

🇦🇪 UAE

🇸🇦 Saudi Arabia

Europe

🇬🇧 UK

North America

🇺🇸 USA
Jun 20th, 2026 10:31 PM

Keywords